Cytodyn Inc (CYDY)

[Saltz]

BP is a tough read. Right now they all know where we stand. Like the rest of the KOL’s and so called experts they all want to see the unblinded data. Anecdotal isn’t going to move the needle the way shareholders believe it should.

I like the way Nader is raving about the way Leronlimab is being handled by the FDA rather than slighting. I also like the way he deals with where the SP has settled. Hey we are up 1000% off our low and the market has decided the $3 range is the appropriate valuation for current progress. If one disagrees and thinks the SP is undervalued then buy more shares.

To answer your question directly I think Gilead for one knows they missed the window and they will not consider ponying up anything close to a reasonable offer —10B / $15SP minimum to even get the BOD attention. If we get FDA approval after the 75 patient trial results then the reasonable buyout just went up to $30 plus.

I know many here believe we shouldn’t settle for anything less than $30. The fact is if an offer is made at 5x current SP it’s going to a vote and would likely pass IMO. Personally that would put me out at over $8M and I’d take it and stay 50% invested in whoever purchased.

Personally I love our positioning right now as news can be released in so many fronts on any given day that will rocket the SP. The only downside is very disappointing Covid trial results that take us out of the Covid story. If that happens we still have an incredible pipeline but it will mean immediate increase in shares, diluting and a longer time line to valuation.

The next month to six weeks is going to be very entertaining.